Compare WVE & APAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | APAM |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | Singapore | United States |
| Employees | N/A | 567 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 2015 | 2011 |
| Metric | WVE | APAM |
|---|---|---|
| Price | $13.35 | $35.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 4 |
| Target Price | $31.47 | ★ $47.00 |
| AVG Volume (30 Days) | ★ 2.2M | 603.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.67% |
| EPS Growth | N/A | ★ 10.66 |
| EPS | N/A | ★ 4.05 |
| Revenue | $3,704,000.00 | ★ $1,196,688,000.00 |
| Revenue This Year | N/A | $7.55 |
| Revenue Next Year | $119.93 | $5.21 |
| P/E Ratio | ★ N/A | $8.96 |
| Revenue Growth | ★ 149.43 | 7.63 |
| 52 Week Low | $5.28 | $32.75 |
| 52 Week High | $21.73 | $48.46 |
| Indicator | WVE | APAM |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 20.98 |
| Support Level | $12.53 | N/A |
| Resistance Level | $14.56 | $45.09 |
| Average True Range (ATR) | 0.79 | 1.17 |
| MACD | 0.01 | -0.51 |
| Stochastic Oscillator | 23.84 | 1.63 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.